Literature DB >> 1500156

Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: the importance of intestinal microflora.

J A Harp1, W Chen, A G Harmsen.   

Abstract

Cryptosporidium parvum is a protozoan parasite which colonizes intestinal epithelium, causing transient diarrheal illness in immunocompetent hosts and severe chronic disease in immunocompromised hosts. We examined the resistance of severe combined immunodeficient mice, either bearing intestinal flora or germfree, to intestinal infection with C. parvum. Infection was not readily detected in flora-bearing adult severe combined immunodeficient mice until 5 to 7 weeks following oral challenge with C. parvum. In contrast, germfree adult severe combined immunodeficient mice were heavily infected 3 weeks following challenge. These data support the hypothesis that resistance of adult mice to C. parvum infection does not require a specific immune response but can be mediated by nonspecific mechanisms associated with the presence of intestinal flora.

Entities:  

Mesh:

Year:  1992        PMID: 1500156      PMCID: PMC257352          DOI: 10.1128/iai.60.9.3509-3512.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.

Authors:  J R Mead; M J Arrowood; R W Sidwell; M C Healey
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

Review 2.  Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse.

Authors:  G J Bancroft; R D Schreiber; E R Unanue
Journal:  Immunol Rev       Date:  1991-12       Impact factor: 12.988

3.  Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.

Authors:  M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1987-04       Impact factor: 1.276

Review 4.  Cryptosporidium spp. and cryptosporidiosis.

Authors:  R Fayer; B L Ungar
Journal:  Microbiol Rev       Date:  1986-12

Review 5.  Human cryptosporidiosis.

Authors:  F G Crawford; S H Vermund
Journal:  Crit Rev Microbiol       Date:  1988       Impact factor: 7.624

6.  Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity.

Authors:  B L Ungar; T C Kao; J A Burris; F D Finkelman
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

7.  Experimental cryptosporidiosis in laboratory mice.

Authors:  D Sherwood; K W Angus; D R Snodgrass; S Tzipori
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

8.  Microbial colonization of the intestinal epithelium in suckling mice.

Authors:  C P Davis; J S McAllister; D C Savage
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

9.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

10.  Experimental cryptosporidiosis in a primate model.

Authors:  R A Miller; M A Bronsdon; W R Morton
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

View more
  33 in total

1.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

2.  [(1)N,(12)N]Bis(Ethyl)-cis-6,7-dehydrospermine: a new drug for treatment and prevention of Cryptosporidium parvum infection of mice deficient in T-cell receptor alpha.

Authors:  W R Waters; B Frydman; L J Marton; A Valasinas; V K Reddy; J A Harp; M J Wannemuehler; N Yarlett
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 3.  SCID mice and the study of parasitic disease.

Authors:  K B Seydel; S L Stanley
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Fecal Indole as a Biomarker of Susceptibility to Cryptosporidium Infection.

Authors:  Cynthia L Chappell; Charles Darkoh; Lawrence Shimmin; Naveed Farhana; Do-Kyun Kim; Pablo C Okhuysen; James Hixson
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

5.  Inferring Metabolic Mechanisms of Interaction within a Defined Gut Microbiota.

Authors:  Gregory L Medlock; Maureen A Carey; Dennis G McDuffie; Michael B Mundy; Natasa Giallourou; Jonathan R Swann; Glynis L Kolling; Jason A Papin
Journal:  Cell Syst       Date:  2018-09-05       Impact factor: 10.304

6.  Diagnostic biomarkers in murine Cryptosporidiosis: dose- and age-related infection.

Authors:  Hebat-Allah S Yousof; Mona M Khater; Shaimaa H El-Sayed; Ayman A El-Badry
Journal:  J Parasit Dis       Date:  2017-02-18

7.  Comparison of Cryptosporidium parvum and Cryptosporidium wrairi by reactivity with monoclonal antibodies and ability to infect severe combined immunodeficient mice.

Authors:  C E Chrisp; P Mason; L E Perryman
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice.

Authors:  W Chen; J A Harp; A G Harmsen
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Cryptosporidium parvum initiates inflammatory bowel disease in germfree T cell receptor-alpha-deficient mice.

Authors:  R E Sacco; J S Haynes; J A Harp; W R Waters; M J Wannemuehler
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice.

Authors:  W Chen; J A Harp; A G Harmsen; E A Havell
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.